When you should—and shouldn’t—use ChatGPT as a therapist, from experts
As Americans get lonelier and lonelier, a growing number of people are getting some emotional support from artificial…
February 2026 jobs report:
The U.S. economy lost jobs in February, a month marred by severe winter weather and a strike at…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Eli Lilly launches Zepbound obesity drug pen with one month of doses
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…
Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion
Hims & Hers Health said on Thursday it will acquire Australian digital health company Eucalyptus in a deal…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
CVS Health (CVS) earnings Q4 2025
A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | Getty…
5 things to know before the stock market opens Monday
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. Congratulations to the…
We’re upgrading shares of a big beneficiary of AI spending going through the roof
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Health insurers tumble after Trump proposes keeping Medicare rates flat
Stock Chart IconStock chart icon Humana shares in the past day The proposal entails a net average payment…
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…